Sonoma Biotherapeutics

Sonoma Biotherapeutics is a company developing adoptive Treg cell therapies for autoimmune and inflammatory diseases. Using genomic editing and targeted specific cell therapies, Sonoma focuses on developing its first-class platform across the full spectrum of Treg cell therapy capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary approaches to discover and develop disease-modifying and curative therapies.